|
⚲
|
| Keyboard |
| Stilwell McDavid
✚
|
|
|---|---|
| CIK # | 0001851389 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001851389] | |
| 4 | [0001851389] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Coherus Oncology Inc | |
| Stilwell McDavid |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Coherus Oncology Inc CHRS
Common Stock
|
2023-12-31 | Tax withheld | 18,440 | $3.33 | 61,405 |
|
Coherus Oncology Inc CHRS
Stock Option (Right to Buy) · derivative
|
2023-06-13 | Grant | 70,000 | $0.00 | |
|
Coherus Oncology Inc CHRS
Common Stock
|
2023-04-01 | Tax withheld | 3,457 | $6.84 | 23,646 |
|
Coherus Oncology Inc CHRS
Common Stock
|
2023-01-20 | Grant | 40,000 | $0.00 | |
|
Coherus Oncology Inc CHRS
Common Stock
|
2023-01-04 | Tax withheld | 5,437 | $9.87 | 53,663 |
|
Coherus Oncology Inc CHRS
Stock Option (Right to Buy) · derivative
|
2023-01-04 | Grant | 80,000 | $0.00 | |
|
Coherus Oncology Inc CHRS
Common Stock
|
2022-04-01 | Tax withheld | 3,458 | $12.85 | 44,435 |
|
Coherus Oncology Inc CHRS
Stock Option (Right to Buy) · derivative
|
2022-01-04 | Grant | 80,000 | $0.00 | |
|
Coherus Oncology Inc CHRS
Common Stock
|
2022-01-04 | Grant | 40,000 | $0.00 | |
|
Coherus Oncology Inc CHRS
Common Stock
|
2021-10-15 | Sell | 3,507 | $16.80 | 58,918 |
|
Coherus Oncology Inc CHRS
Common Stock
|
2021-06-09 | Buy | 3,700 | $13.42 | 49,654 |
|
Coherus Oncology Inc CHRS
Stock Option (Right to Buy) · derivative
|
2021-04-28 | Grant | 50,000 | $0.00 | |
|
Coherus Oncology Inc CHRS
Common Stock
|
2021-04-28 | Grant | 20,000 | $0.00 |